tm logo
KRAZATI
Live/Registered
REGISTERED

on 05 Sep 2023

Last Applicant/ Owned by

3545 Cray Court

San Diego

CA

92121

Serial Number

97541596 filed on 09th Aug 2022

Registration Number

7159328 registered on 05th Sep 2023

in the Principal Register

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb Company

Trademark Dept., Mailstop D.4243

Princeton, NJ 08648-4000

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

KRAZATI

research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals


First Use Date in General

13th Dec 2022

First Use Date in Commerce

13th Dec 2022

Class [005]
Pharmaceutical Products


pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors


First Use Date in General

13th Dec 2022

First Use Date in Commerce

13th Dec 2022

Mark Details


Serial Number

No 97541596

Mark Type

No Service Mark

Attorney Docket Number

No 00163763-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Jun 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Jun 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
25th Jun 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
05th Sep 2023REGISTERED-PRINCIPAL REGISTER
02th Aug 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01st Aug 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th May 2023STATEMENT OF USE PROCESSING COMPLETE
08th May 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
19th Apr 2023USE AMENDMENT FILED